Marinomed Biotech AG (WBO:MARI) FFO


WBO:MARI Marinomed Biotech AG WBO:MARI
42 GF Score
Price €9.20
GF Value €18.48
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Marinomed Biotech AG FFO?

FFO (Funds from operations) only applies to REITs.

WBO:MARI
42GF Score
Marinomed Biotech AG WBO:MARI
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Marinomed Biotech AG (WBO:MARI) Overvalued in 2026?

Based on GuruFocus' analysis, Marinomed Biotech AG stock appears to be undervalued. The current stock price of €9.20 is trading 50.2% below its estimated GF Value™ of €18.48. GuruFocus considers Marinomed Biotech AG to be Possible Value Trap.

Key valuation signals for WBO:MARI:

  • FFO:
  • GF Value™: €18.48 vs. price of €9.20 (50.2% below fair value)
  • GF Score™: 42/100 with 7 warning signs

No single metric tells the full story. See the WBO:MARI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Marinomed Biotech AG Business Description

Other Exchanges 93Z:Germany
Address Hovengasse 25, Korneuburg, AUT, 2100
Marinomed Biotech AG is a biopharmaceutical company focusing on the development of products in the field of respiratory and ophthalmological diseases. The company develops products for cough, cold, influenza, allergic rhinitis, and ophthalmic diseases. Its product offerings include virus-blocking nasal sprays, virus-blocking decongestant nasal sprays, virus-blocking lozenges, and virus-blocking throat sprays. The company has two reportable segments which are Virology, Immunology, and other, the majority of revenue generated from the virology segment.
42GF Score

Get the complete analysis for WBO:MARI

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€9.20
Price
€18.48
GF Value